ATE479773T1 - Gen zum nachweis von patienten mit familiärer dysautonomie - Google Patents

Gen zum nachweis von patienten mit familiärer dysautonomie

Info

Publication number
ATE479773T1
ATE479773T1 AT02714715T AT02714715T ATE479773T1 AT E479773 T1 ATE479773 T1 AT E479773T1 AT 02714715 T AT02714715 T AT 02714715T AT 02714715 T AT02714715 T AT 02714715T AT E479773 T1 ATE479773 T1 AT E479773T1
Authority
AT
Austria
Prior art keywords
mutation
haplotype
patients
gene
exon
Prior art date
Application number
AT02714715T
Other languages
English (en)
Inventor
Susan Slaugenhaupt
James Gusella
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22987684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE479773(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE479773T1 publication Critical patent/ATE479773T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02714715T 2001-01-06 2002-01-07 Gen zum nachweis von patienten mit familiärer dysautonomie ATE479773T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26008001P 2001-01-06 2001-01-06
PCT/US2002/000473 WO2002059381A2 (en) 2001-01-06 2002-01-07 Gene for identifying individuals with familial dysautonomia

Publications (1)

Publication Number Publication Date
ATE479773T1 true ATE479773T1 (de) 2010-09-15

Family

ID=22987684

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02714715T ATE479773T1 (de) 2001-01-06 2002-01-07 Gen zum nachweis von patienten mit familiärer dysautonomie

Country Status (7)

Country Link
US (5) US7388093B2 (de)
EP (1) EP1373568B1 (de)
AT (1) ATE479773T1 (de)
CA (1) CA2433869C (de)
DE (1) DE60237509D1 (de)
IL (2) IL156752A0 (de)
WO (1) WO2002059381A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388093B2 (en) 2001-01-06 2008-06-17 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
US20190276891A1 (en) * 2001-01-06 2019-09-12 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
IL142015A0 (en) * 2001-01-17 2002-03-10 Detection of mutations in a gene encoding 1kb kinase-complex-associated protein to diagnose familial dysautonomia
WO2005033290A2 (en) * 2003-10-03 2005-04-14 The General Hospital Corporation Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
EP1743012A4 (de) * 2004-04-09 2008-08-27 Ronald S Coldstein Verfahren zur generierung von neuronalen zellen aus menschlichen embryonalen stammzellen und verwendungen dafür
IL266882B2 (en) 2012-01-11 2025-11-01 Ionis Pharmaceuticals Inc Compositions and methods for modulation of ikbkap splicing
BR112022021964A2 (pt) * 2020-04-28 2023-03-14 Pfizer Ácidos nucleicos modificados que codificam aspartoacilase (aspa) e vetores para terapia gênica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217863A (en) * 1988-02-04 1993-06-08 Medical Research Council Detection of mutations in nucleic acids
US5387506A (en) * 1992-05-29 1995-02-07 The General Hospital Corporation Use of genetic markers to diagnose familial dysautonomia
GB2282446B (en) 1992-05-29 1996-10-02 Gen Hospital Corp Use of genetic markers to diagnose familial dysautonomia
FR2722295B1 (fr) 1994-07-07 1996-10-04 Roussy Inst Gustave Methode d'analyse d'adn dite sscp et gel d'electro-phorene
US5597898A (en) * 1995-02-15 1997-01-28 Yale University NF-κB activation regulatory protein, IκB-β
US5968740A (en) * 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
MX9802356A (es) * 1995-09-26 1998-07-31 Univ Washington Glicoproteina b de la subfamilia rfhv/kshv de virus de herpes.
US6183952B1 (en) * 1996-08-19 2001-02-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US5891719A (en) 1997-11-16 1999-04-06 Tularik Inc. IKAP nucleic acids
JP2002502614A (ja) * 1998-02-04 2002-01-29 バリアジェニックス インク． ミスマッチ検出技術
CA2403696A1 (en) 2000-03-15 2001-09-20 The General Hospital Corporation Use of genetic markers to diagnose familial dysautonomia
US7388093B2 (en) * 2001-01-06 2008-06-17 The General Hospital Corporation Gene for identifying individuals with familial dysautonomia
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
IL142015A0 (en) 2001-01-17 2002-03-10 Detection of mutations in a gene encoding 1kb kinase-complex-associated protein to diagnose familial dysautonomia

Also Published As

Publication number Publication date
US20090176222A1 (en) 2009-07-09
US7407756B2 (en) 2008-08-05
HK1061702A1 (en) 2004-09-30
DE60237509D1 (de) 2010-10-14
CA2433869A1 (en) 2002-08-01
CA2433869C (en) 2015-11-24
EP1373568A2 (de) 2004-01-02
WO2002059381A3 (en) 2003-10-09
IL156752A0 (en) 2004-02-08
US7388093B2 (en) 2008-06-17
US20160265052A1 (en) 2016-09-15
WO2002059381A2 (en) 2002-08-01
US20020169299A1 (en) 2002-11-14
EP1373568B1 (de) 2010-09-01
IL156752A (en) 2013-08-29
US20130066060A1 (en) 2013-03-14
US20050204409A1 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
Bauwens et al. An Augmented ABCA 4 Screen Targeting Noncoding Regions Reveals a Deep Intronic Founder Variant in B elgian S targardt Patients
Williams et al. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease
Salisbury et al. SNP and haplotype variation in the human genome
Hildebrand et al. DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss
Belmouden et al. A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco
Torres et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus
ES2698114T3 (es) Materiales y procedimiento para identificar portadores de atrofia muscular espinal
Lombardi et al. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing.
Spena et al. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
ATE479773T1 (de) Gen zum nachweis von patienten mit familiärer dysautonomie
Frio et al. A single‐base substitution within an intronic repetitive element causes dominant retinitis pigmentosa with reduced penetrance
Inoue et al. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement
Farahani et al. RAR‐related orphan receptor A: One gene with multiple functions related to migraine
Fanis et al. Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect
Sharon et al. Identification and characterization of coding single-nucleotide polymorphisms within a human olfactory receptor gene cluster
Park et al. The association of osteoprotegerin gene polymorphisms with periodontitis
Mukherjee et al. Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene
Fuchs‐Telem et al. New intragenic and promoter region deletion mutations in FERMT1 underscore genetic homogeneity in Kindler syndrome
Västinsalo et al. Extended mutation spectrum of Usher syndrome in Finland
Franco et al. Relative frequencies of the two 0 alleles of the histo-blood ABH system in different racial groups
Priyadarshi et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients
Mostowska et al. Association between polymorphisms at the GREM1 locus and the risk of nonsyndromic cleft lip with or without cleft palate in the Polish population
Alavi et al. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients
Seddon et al. Evolutionary history of DLA class II haplotypes in canine diabetes mellitus through single nucleotide polymorphism genotyping
Feuk et al. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties